Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of APG-1252 in Patients With Myelofibrosis Who Progressed After Initial Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Ruxolitinib to Combat COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Efficacy of Ruxolitinib for COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia
- Status
- TERMINATED
- Phase
- NA
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE2
Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Actuate 1901: 9-ING-41 in Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
- Status
- RECRUITING
- Phase
- PHASE3
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2